KYORIN Pharmaceutical Co.,Ltd. 4569Short Interest
Estimated short interest in KYORIN Pharmaceutical Co.,Ltd. (4569) is 1.14% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, MERRILL LYNCH INTERNATIONAL.
Estimated short interest
1.14%
±0.00%
Estimated position (shares)
688,575
As of 2026-11-18
Holders (0.5% or more)
2 firms
87 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 1 institutions whose last report is more than a year old (0.54% in total). It also excludes 6 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2018-11-30 |
|---|---|
| Latest disclosure | 2026-11-16 (GOLDMAN SACHS INTERNATIONAL, 0.49%) |
| Reporting institutions | 11 firms (87 reports) |
| Peak estimated short interest | 1.84% (2026-06-25, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- MERRILL LYNCH INTERNATIONAL
- Citigroup Global Markets Limited
- GOLDMAN SACHS INTERNATIONAL
- Daiwa Securities Co. Ltd.
1.14%
Estimated short interest, 2026-11-18
MERRILL LYNCH INTERNATIONAL0.52%
Barclays Capital Securities Ltd0.62%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-04 | Barclays Capital Securities Ltd | Position 375,200 shares | Ratio 0.62% | ▲0.15% | Holding |
| 2018-11-30 | Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP | Position 355,300 shares | Ratio 0.54% | ▲0.08% | No report for 1+ year |
| 2026-11-13 | MERRILL LYNCH INTERNATIONAL | Position 313,375 shares | Ratio 0.52% | ▲0.01% | Holding |
| 2021-05-31 | UBS AG | Position 317,900 shares | Ratio 0.49% | ▼0.02% | Below 0.5% |
| 2026-06-05 | Daiwa Securities Co. Ltd. | Position 297,561 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-11-16 | GOLDMAN SACHS INTERNATIONAL | Position 293,884 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2019-07-02 | Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP | Position 288,735 shares | Ratio 0.45% | ▼0.10% | Below 0.5% |
| 2020-03-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 287,169 shares | Ratio 0.44% | ▼0.10% | Below 0.5% |
| 2018-12-21 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 212,700 shares | Ratio 0.32% | ▼0.18% | Below 0.5% |
| 2019-12-10 | Credit Suisse AG | Position 0 shares | Ratio 0.00% | ▼0.78% | Closed |
| 2026-08-31 | Citigroup Global Markets Limited | Position 0 shares | Ratio 0.00% | ▼1.10% | Closed |
Disclosure History 87 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-16 | GOLDMAN SACHS INTERNATIONAL | Position 293,884 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2026-11-13 | MERRILL LYNCH INTERNATIONAL | Position 313,375 shares | Ratio 0.52% | ▲0.01% | — |
| 2026-11-12 | MERRILL LYNCH INTERNATIONAL | Position 307,375 shares | Ratio 0.51% | ▼0.01% | — |
| 2026-11-11 | MERRILL LYNCH INTERNATIONAL | Position 317,475 shares | Ratio 0.52% | ▲0.01% | — |
| 2026-11-10 | MERRILL LYNCH INTERNATIONAL | Position 310,275 shares | Ratio 0.51% | ▼0.01% | — |
| 2026-11-06 | MERRILL LYNCH INTERNATIONAL | Position 314,075 shares | Ratio 0.52% | ▼0.01% | — |
| 2026-11-05 | GOLDMAN SACHS INTERNATIONAL | Position 355,284 shares | Ratio 0.59% | ▼0.09% | — |
| 2026-11-04 | MERRILL LYNCH INTERNATIONAL | Position 323,275 shares | Ratio 0.53% | ▼0.01% | — |
| 2026-11-04 | Barclays Capital Securities Ltd | Position 375,200 shares | Ratio 0.62% | ▲0.15% | — |
| 2026-10-30 | MERRILL LYNCH INTERNATIONAL | Position 324,075 shares | Ratio 0.54% | ▼0.01% | — |
| 2026-10-29 | MERRILL LYNCH INTERNATIONAL | Position 329,775 shares | Ratio 0.55% | ▲0.02% | — |
| 2026-10-29 | GOLDMAN SACHS INTERNATIONAL | Position 408,884 shares | Ratio 0.68% | ▼0.03% | — |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 283,200 shares | Ratio 0.47% | ▼0.08% | Below 0.5% |
| 2026-10-28 | MERRILL LYNCH INTERNATIONAL | Position 323,319 shares | Ratio 0.53% | ▲0.02% | — |
| 2026-10-28 | GOLDMAN SACHS INTERNATIONAL | Position 431,184 shares | Ratio 0.71% | ▲0.02% | — |
| 2026-10-28 | Barclays Capital Securities Ltd | Position 335,500 shares | Ratio 0.55% | ▼0.05% | — |
| 2026-10-27 | MERRILL LYNCH INTERNATIONAL | Position 310,419 shares | Ratio 0.51% | ▲0.02% | — |
| 2026-10-21 | MERRILL LYNCH INTERNATIONAL | Position 295,719 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2026-10-20 | MERRILL LYNCH INTERNATIONAL | Position 314,163 shares | Ratio 0.52% | ▲0.01% | — |
| 2026-10-19 | GOLDMAN SACHS INTERNATIONAL | Position 418,984 shares | Ratio 0.69% | ▼0.01% | — |
| 2026-10-16 | MERRILL LYNCH INTERNATIONAL | Position 307,163 shares | Ratio 0.51% | ▼0.02% | — |
| 2026-10-15 | GOLDMAN SACHS INTERNATIONAL | Position 420,984 shares | Ratio 0.70% | ▲0.02% | — |
| 2026-10-13 | MERRILL LYNCH INTERNATIONAL | Position 323,263 shares | Ratio 0.53% | ▲0.02% | — |
| 2026-10-09 | GOLDMAN SACHS INTERNATIONAL | Position 412,384 shares | Ratio 0.68% | ▼0.02% | — |
| 2026-10-08 | MERRILL LYNCH INTERNATIONAL | Position 306,763 shares | Ratio 0.51% | ▲0.01% | — |
| 2026-10-07 | MERRILL LYNCH INTERNATIONAL | Position 301,763 shares | Ratio 0.50% | ▲0.01% | — |
| 2026-10-05 | GOLDMAN SACHS INTERNATIONAL | Position 422,784 shares | Ratio 0.70% | ▲0.07% | — |
| 2026-10-02 | Barclays Capital Securities Ltd | Position 364,500 shares | Ratio 0.60% | ▲0.10% | — |
| 2026-10-01 | GOLDMAN SACHS INTERNATIONAL | Position 383,484 shares | Ratio 0.63% | ▲0.13% | — |
| 2026-09-28 | Barclays Capital Securities Ltd | Position 303,300 shares | Ratio 0.50% | ▲0.08% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| OncoTherapy Science,Inc.4564 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nxera Pharma Co.,Ltd.4565 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| DAIICHI SANKYO COMPANY,LIMITED4568 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Immuno-Biological Laboratories Co.,Ltd.4570 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Nano Holdings,Inc.4571 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Carna Biosciences,Inc.4572 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAIKO PHARMACEUTICAL CO.,LTD.4574 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CanBas Co.,Ltd.4575 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |